Although ERK’s effects on neurodegeneration in other conditions has been debated [48], [49], previous studies have been concordant in showing that ERK activation achieves neuroprotection against HD when ERK is regulated endogenously, regulated by small molecules, or activated via BDNF signaling [42], [43], [50], [51]. The gene discussed is BDNF; the disease is Huntington disease.